About Us
People worldwide affected by inflammatory effects or tissue degeneration are estimated of about to 50% of total population. More methods are used to reduce the problematic by hyaluronic acid and the corticoid injections that are the must applied for inflammatory care and general chirurgical solution for tissue care. Another care method of these pathologies is based on the inflammatory effects and tissue degeneration and local globular adipose tissue injections.
Theralip SA based in Cureglia develops, manufactures, and sells medical devices to improve regenerative medicine procedures aimed at restoring or improving functioning: of organs and tissues damaged by aging, or caused by pathological events or traumas.For this reason,
Theralip SA has developed an innovative therapeutic solution that uses a suitably engineered device to obtain an injectable or cryopreservable tissue based on previously lipo-aspirated autologous adipose tissue globules (hADSC Human Adipose-Derived Stem Cells).
The founders of Theralip SA are people with many years of experience in the pharmaceutical, biotechnological and economic fields


Mission & Vision
Innovative technological solutions for healthcare, for the most complex and difficult to treat pathologies.
Offering new opportunities to people all over the world.